These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 37960876)
1. The value of a three-microRNA panel in serum for prostate cancer screening. Lin S; Sun C; Li R; Lu C; Li X; Wen Z; Ge Z; Chen W; Li Y; Li H; Lai Y Int J Biol Markers; 2024 Mar; 39(1):70-79. PubMed ID: 37960876 [TBL] [Abstract][Full Text] [Related]
2. Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test. Li R; Xia Y; Chen X; Li X; Huang G; Peng X; Liu K; Zhang C; Li M; Lin Y; Dong J; Ji L; Lai Y Transl Cancer Res; 2022 May; 11(5):1005-1016. PubMed ID: 35706801 [TBL] [Abstract][Full Text] [Related]
3. Identification of a four-microRNA panel in serum for screening renal cell carcinoma. Chen X; Li R; Li X; Peng X; Zhang C; Liu K; Huang G; Lai Y Pathol Res Pract; 2021 Nov; 227():153625. PubMed ID: 34628264 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic panel of serum miR-125b-5p, miR-182-5p, and miR-200c-3p as non-invasive biomarkers for urothelial bladder cancer. Wen Z; Huang G; Lai Y; Xiao L; Peng X; Liu K; Zhang C; Chen X; Li R; Li X; Lai Y; Ni L Clin Transl Oncol; 2022 May; 24(5):909-918. PubMed ID: 35028929 [TBL] [Abstract][Full Text] [Related]
5. Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study. Lu C; Lin S; Wen Z; Sun C; Ge Z; Chen W; Li Y; Zhang P; Wu Y; Wang W; Chen S; Zhou H; Li X; Li H; Tao L; Hu Y; Zhao Z; Chen Z; Wu X; Lai Y Biomarkers; 2024 Jul; 29(5):276-284. PubMed ID: 38767408 [TBL] [Abstract][Full Text] [Related]
6. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer. Zhu XL; Ren LF; Wang HP; Bai ZT; Zhang L; Meng WB; Zhu KX; Ding FH; Miao L; Yan J; Wang YP; Liu YQ; Zhou WC; Li X World J Gastroenterol; 2019 Apr; 25(13):1580-1591. PubMed ID: 30983818 [TBL] [Abstract][Full Text] [Related]
7. Identification of a six-miRNA panel in serum benefiting pancreatic cancer diagnosis. Zou X; Wei J; Huang Z; Zhou X; Lu Z; Zhu W; Miao Y Cancer Med; 2019 Jun; 8(6):2810-2822. PubMed ID: 31006985 [TBL] [Abstract][Full Text] [Related]
8. A Three-microRNA Panel in Serum: Serving as a Potential Diagnostic Biomarker for Renal Cell Carcinoma. Huang G; Li X; Chen Z; Wang J; Zhang C; Chen X; Peng X; Liu K; Zhao L; Lai Y; Ni L Pathol Oncol Res; 2020 Oct; 26(4):2425-2434. PubMed ID: 32556891 [TBL] [Abstract][Full Text] [Related]
9. Serum Levels of miR-223-3p and miR-223-5p in Prostate Diseases. Dülgeroğlu Y; Eroğlu O Microrna; 2020; 9(4):303-309. PubMed ID: 33155933 [TBL] [Abstract][Full Text] [Related]
10. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of lung cancer. Zhang Y; Sui J; Shen X; Li C; Yao W; Hong W; Peng H; Pu Y; Yin L; Liang G Oncol Rep; 2017 Jun; 37(6):3543-3553. PubMed ID: 28498428 [TBL] [Abstract][Full Text] [Related]
11. A panel of seven-miRNA signature in plasma as potential biomarker for colorectal cancer diagnosis. Zhang H; Zhu M; Shan X; Zhou X; Wang T; Zhang J; Tao J; Cheng W; Chen G; Li J; Liu P; Wang Q; Zhu W Gene; 2019 Mar; 687():246-254. PubMed ID: 30458288 [TBL] [Abstract][Full Text] [Related]
12. A Panel of MicroRNAs as Diagnostic Biomarkers for the Identification of Prostate Cancer. Daniel R; Wu Q; Williams V; Clark G; Guruli G; Zehner Z Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28621736 [TBL] [Abstract][Full Text] [Related]
13. A three-miRNA panel in serum as a noninvasive biomarker for colorectal cancer detection. Peng X; Wang J; Zhang C; Liu K; Zhao L; Chen X; Huang G; Lai Y Int J Biol Markers; 2020 Sep; 35(3):74-82. PubMed ID: 32914665 [TBL] [Abstract][Full Text] [Related]
14. Identification of a serum microRNA expression signature for detection of lung cancer, involving miR-23b, miR-221, miR-148b and miR-423-3p. Zhu Y; Li T; Chen G; Yan G; Zhang X; Wan Y; Li Q; Zhu B; Zhuo W Lung Cancer; 2017 Dec; 114():6-11. PubMed ID: 29173767 [TBL] [Abstract][Full Text] [Related]
15. Five serum-based miRNAs were identified as potential diagnostic biomarkers in gastric cardia adenocarcinoma. Wang J; Zhang H; Zhou X; Wang T; Zhang J; Zhu W; Zhu H; Cheng W Cancer Biomark; 2018; 23(2):193-203. PubMed ID: 30198863 [TBL] [Abstract][Full Text] [Related]
16. Five serum microRNAs for detection and predicting of ovarian cancer. Wang W; Wu LR; Li C; Zhou X; Liu P; Jia X; Chen Y; Zhu W Eur J Obstet Gynecol Reprod Biol X; 2019 Jul; 3():100017. PubMed ID: 31404211 [TBL] [Abstract][Full Text] [Related]
17. Identification of a 7-microRNA signature in plasma as promising biomarker for nasopharyngeal carcinoma detection. Zhang H; Zou X; Wu L; Zhang S; Wang T; Liu P; Zhu W; Zhu J Cancer Med; 2020 Feb; 9(3):1230-1241. PubMed ID: 31856390 [TBL] [Abstract][Full Text] [Related]
18. Development and validation of a urinary microRNA biomarker panel as a tool for early detection of prostate cancer in a Chinese population. Zhang N; Wang J; Zhang S; Wu H; Li Z; Hu M Biomarkers; 2023 Jun; 28(4):372-378. PubMed ID: 37185057 [TBL] [Abstract][Full Text] [Related]
19. A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis. Zou X; Gao F; Wang ZY; Zhang H; Liu QX; Jiang L; Zhou X; Zhu W Chin Med J (Engl); 2020 Nov; 133(21):2543-2551. PubMed ID: 33009019 [TBL] [Abstract][Full Text] [Related]